SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AdipoPharma Advances PATAS Into Phase 1b Trial in Type 2 Diabetes Patients

AdipoPharma has advanced PATAS into a Phase 1b clinical trial in patients with type 2 diabetes.

SquawkNews Desk 1 updates Updated Oct 27, 2026, 02:22 PM UTC

Story updates

02:22:31 PM UTC
SquawkNews
First participants with Type 2 diabetes dosed in multiple ascending dose (MAD) study evaluating Adip

Related stories

Samsung SDI to Supply Batteries to Jupiter Power Samsung SDI says it will supply batteries to Jupiter Power for three years starting in 2029. M impact | EQUITY | Nov 15, 2026, 11:18 PM UTC More Than 10,000 US Flights Affected for Third Day US air travel disruptions continued Sunday, with Transportation Secretary Sean Duffy predicting a return to normal by Monday as airlines worked to restore schedules. M impact | EQUITY | Nov 15, 2026, 11:11 PM UTC Thousands of US Flights Canceled, Delayed for Third Day in a Row M impact | EQUITY | Nov 15, 2026, 11:11 PM UTC Boeing-Lockheed Rocket Fails Mid-Flight, Destroying Amazon Satellites M impact | EQUITY | Nov 15, 2026, 11:09 PM UTC Samsung SDI Wins 16 GWh Battery Order From Jupiter Power Samsung SDI's U.S. subsidiary signed an order for 16 GWh of batteries from Jupiter Power. M impact | EQUITY | Nov 15, 2026, 11:05 PM UTC Intel shareholders sue after 29% stock plunge Intel shareholders sued the company following a 29% stock plunge, Reuters reported. M impact | EQUITY | Nov 15, 2026, 11:03 PM UTC